Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

5.3K
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
5.3K
Peroxisomes01:24

Peroxisomes

20.0K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
20.0K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

215
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
215
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

697
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
697
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

4.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loss of peroxisomal membrane proteins PEX13 and PEX14 disrupts fatty acid oxidation and drives lipid imbalance.

Bioscience reports·2026
Same author

An Association Between Haemochromatosis Genotypes and Venous Leg Ulcers in Australian Individuals.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society·2026
Same author

Mechanisms of liver regeneration and their relevance to steatotic liver disease.

American journal of physiology. Gastrointestinal and liver physiology·2025
Same author

Three-Dimensional Dynamic Cell Models for Metabolic Dysfunction-Associated Steatotic Liver Disease Progression.

BME frontiers·2025
Same author

A novel human hepatocyte cell line to study PNPLA3-associated steatotic liver disease.

American journal of physiology. Gastrointestinal and liver physiology·2025
Same author

A novel saliva-based miRNA profile to diagnose and predict oral cancer.

International journal of oral science·2024

Related Experiment Video

Updated: Jan 18, 2026

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.6K

Peroxisome Dysfunction and Steatotic Liver Disease.

Navia Vinoy1,2, Gary Huang1,2, Daniel F Wallace2,3

  • 1Hepatogenomics Research Group, Queensland University of Technology (QUT), Brisbane, QLD 4059, Australia.

International Journal of Molecular Sciences
|September 13, 2025
PubMed
Summary

Peroxisomal defects may contribute to metabolic dysfunction-associated steatotic liver disease (MASLD). This review explores the potential link between peroxisome dysfunction and the development of MASLD.

Keywords:
beta-oxidationfatty acid oxidationfatty acid synthesisliver diseasemetabolic dysfunction-associated steatotic liver diseaseperoxisomes

More Related Videos

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

8.5K
A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

7.5K

Related Experiment Videos

Last Updated: Jan 18, 2026

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.6K
Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

8.5K
A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

7.5K

Area of Science:

  • Cellular Biology
  • Metabolic Disorders
  • Hepatology

Background:

  • Peroxisomes are vital organelles for lipid metabolism and reactive oxygen species detoxification.
  • Peroxisomal disorders result from genetic defects, causing diverse clinical manifestations, including liver issues.
  • Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health concern.

Purpose of the Study:

  • To investigate the potential role of peroxisomal dysfunction in the pathogenesis of MASLD.
  • To review current understanding of peroxisomal disorders and their connection to liver disease.
  • To highlight areas for future research into peroxisome-MASLD interactions.

Main Methods:

  • Literature review of peroxisomal disorders and MASLD.
  • Analysis of molecular mechanisms linking peroxisomal function to liver health.
  • Synthesis of evidence for peroxisomal involvement in MASLD development.

Main Results:

  • Peroxisomal defects can lead to metabolic disturbances relevant to liver steatosis.
  • Specific peroxisomal enzymes and biogenesis pathways are implicated in lipid metabolism.
  • Evidence suggests a plausible connection between impaired peroxisomal function and MASLD pathogenesis.

Conclusions:

  • Peroxisomal dysfunction represents a potential contributing factor to MASLD.
  • Further research is warranted to elucidate the precise mechanisms linking peroxisomes and MASLD.
  • Understanding this link may offer novel therapeutic targets for MASLD.